Better Care, Everywhere
What if anyone could quickly, accurately, and cheaply identify any infection
from the comfort of their own home?
Our mission is to democratize access to diagnostics with our state-of-the-art molecular testing platform.
WHY EN CARTA
GROUNDBREAKING PROPRIETARY TECHNOLOGY
Our lab-grade molecular tests detect pathogenic genetic information with PCR accuracy without the need for specialized equipment or medical professionals, while producing no toxic waste.
FAST PRODUCT DEVELOPMENT
Our development cycle is fast with in-silico discovery achievable in a matter of days.
We quickly develop exactly the diagnostic you are looking for.
IMPACT AND SUSTAINABILITY
We are mindful of sustainability goals and aim to transform point-of-care diagnostics while creating a minimal carbon footprint.
Our vision is to use our technology to develop point-of-care nucleic acid diagnostics for pathogens like HIV, TB, and HPV with specificity down to the single-nucleotide level and costs below $1.
These diagnostics will benefit from the extremely low cost of paper-based molecular systems, ensuring room temperature stability for up to a year.
En Carta Diagnostics
If you are interested in our products, our company or have an idea, we want to hear from you!